Wall Street Zen upgraded shares of Omega Healthcare Investors (NYSE:OHI – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday,Wall Street Zen reports.
A number of other equities analysts also recently weighed in on OHI. Cantor Fitzgerald lifted their target price on shares of Omega Healthcare Investors from $52.00 to $56.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Wells Fargo & Company dropped their target price on shares of Omega Healthcare Investors from $49.00 to $48.00 and set an “equal weight” rating on the stock in a report on Tuesday, September 1st. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Omega Healthcare Investors in a research report on Friday, September 25th. Barclays cut their price target on shares of Omega Healthcare Investors from $50.00 to $48.00 and set an “underweight” rating on the stock in a research report on Tuesday. Finally, Mizuho increased their price target on Omega Healthcare Investors from $45.00 to $46.00 and gave the stock a “neutral” rating in a report on Monday, August 31st. Six investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $49.93.
View Our Latest Stock Analysis on Omega Healthcare Investors
Omega Healthcare Investors Stock Performance
NYSE:OHI opened at $45.68 on Friday. The company has a market capitalization of $13.84 billion, a PE ratio of 16.31, a P/E/G ratio of 1.84 and a beta of 0.53. The company has a 50 day simple moving average of $46.24 and a two-hundred day simple moving average of $46.91. Omega Healthcare Investors has a fifty-two week low of $39.26 and a fifty-two week high of $52.39.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.68. The firm had revenue of $328.25 million during the quarter, compared to analyst estimates of $266.97 million. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The company’s revenue was up 16.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.77 EPS. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. Research analysts predict that Omega Healthcare Investors will post 3.12 EPS for the current year.
Omega Healthcare Investors Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, August 3rd were paid a $0.68 dividend. This represents a $2.72 annualized dividend and a yield of 6.0%. This is a boost from Omega Healthcare Investors’s previous quarterly dividend of $0.67. The ex-dividend date of this dividend was Monday, August 3rd. Omega Healthcare Investors’s payout ratio is presently 97.14%.
Hedge Funds Weigh In On Omega Healthcare Investors
A number of institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. acquired a new position in Omega Healthcare Investors during the second quarter worth $1,838,155,000. Bank of New York Mellon Corp acquired a new position in shares of Omega Healthcare Investors during the second quarter valued at about $275,230,000. Bank of America Corp DE acquired a new position in shares of Omega Healthcare Investors during the second quarter valued at about $137,876,000. Legal & General Group Plc acquired a new position in shares of Omega Healthcare Investors during the second quarter valued at about $88,363,000. Finally, Jupiter Topco LLC bought a new stake in shares of Omega Healthcare Investors during the second quarter worth about $50,271,000. 65.25% of the stock is currently owned by institutional investors.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a real estate investment trust (REIT) focused on healthcare facilities, with an emphasis on skilled nursing and assisted living properties. The company owns or invests in healthcare real estate and leases its properties to operators that provide care and related services to residents.
Omega generally uses long-term, predominantly triple-net lease arrangements, under which tenants are responsible for many property-level expenses, including maintenance, insurance and taxes.
See Also
- Five stocks we like better than Omega Healthcare Investors
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
